HIV preexposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate among cisgender women
J Marrazzo, L Tao, M Becker, AA Leech, AW Taylor… - JAMA, 2024 - jamanetwork.com
Importance Emtricitabine and tenofovir disoproxil fumarate (F/TDF) for HIV preexposure
prophylaxis (PrEP) is highly effective in cisgender men who have sex with men (MSM) when …
prophylaxis (PrEP) is highly effective in cisgender men who have sex with men (MSM) when …
Trajectories of Pre-exposure Prophylaxis Adherence Among Commercially Insured Individuals
I Unigwe, A Goodin, WH Lo-Ciganic… - Clinical Infectious …, 2024 - academic.oup.com
We used group-based trajectory models to identify 4 distinct trajectory patterns of adherence
to preexposure prophylaxis (PrEP) among 20 696 users. Only 44.5% were consistently PrEP …
to preexposure prophylaxis (PrEP) among 20 696 users. Only 44.5% were consistently PrEP …
Interventions to Improve Adherence to Oral Pre-exposure Prophylaxis: A Systematic Review and Network Meta-analysis
C Garcia, N Rehman, J Matos-Silva, J Deng… - AIDS and Behavior, 2024 - Springer
For people at risk of HIV infection, pre-exposure prophylaxis (PrEP) can reduce the risk of
infection in anticipation of exposure to HIV. The effectiveness of PrEP relies upon a user's …
infection in anticipation of exposure to HIV. The effectiveness of PrEP relies upon a user's …
Integrating sexual and reproductive health into pre-travel consultations
C Santaolaya, J Malhotra, JA Fowler… - Journal of Travel …, 2024 - academic.oup.com
Background Casual sex during travel is a major preventable factor in the global transmission
of sexually transmissible infections (STI). Pre-travel consults present an excellent …
of sexually transmissible infections (STI). Pre-travel consults present an excellent …
Gender affirming hormones do not affect the exposure and efficacy of F/TDF or F/TAF for HIV preexposure prophylaxis: a subgroup analysis from the DISCOVER trial
MS Cespedes, M Das, J Yager, M Prins… - Transgender …, 2024 - liebertpub.com
Purpose: Transgender women are disproportionately affected by HIV and are underutilizing
preexposure prophylaxis (PrEP). The lower uptake of PrEP by transgender women may be …
preexposure prophylaxis (PrEP). The lower uptake of PrEP by transgender women may be …
Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate …
RJ Landovitz, L Tao, J Yang, M de Boer… - Clinical Infectious …, 2024 - academic.oup.com
Background Oral pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil
fumarate (F/TDF) has high efficacy against HIV-1 acquisition. Seventy-two prospective …
fumarate (F/TDF) has high efficacy against HIV-1 acquisition. Seventy-two prospective …
A scripted, PrEP-using peer change agent improves perceived risk for HIV and willingness to accept referrals quickly among Black sexual minority men: preliminary …
DT Dangerfield Ii, JN Anderson - AIDS and Behavior, 2024 - Springer
PrEP use remains suboptimal among Black sexual minority men (SMM) partly due to low
perceived risk for HIV (PRH). This study describes baseline results of POSSIBLE, a …
perceived risk for HIV (PRH). This study describes baseline results of POSSIBLE, a …
Longitudinal evolution of the HIV effective reproduction number following sequential expansion of treatment as prevention and pre-exposure prophylaxis in British …
Background Treatment as prevention and pre-exposure prophylaxis (PrEP) are key
strategies in the control of HIV/AIDS. We aimed to characterise the longitudinal effects of …
strategies in the control of HIV/AIDS. We aimed to characterise the longitudinal effects of …
Pilot randomized controlled trial of game plan for PrEP: a brief, web and text message intervention to help sexual minority men adhere to PrEP and reduce their …
Suboptimal adherence to oral PrEP medications, particularly among younger sexual
minority men (SMM), continues to be a key barrier to achieving more substantial declines in …
minority men (SMM), continues to be a key barrier to achieving more substantial declines in …
Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabine
S Chawki, L Goldwirt, M El Mouhebb, A Gabassi… - AIDS, 2024 - journals.lww.com
Objectives: We wished to assess time to protection from HIV-1 infection following oral
tenofovir disoproxil and emtricitabine (TDF/FTC) as preexposure prophylaxis (PrEP), using …
tenofovir disoproxil and emtricitabine (TDF/FTC) as preexposure prophylaxis (PrEP), using …